357 related articles for article (PubMed ID: 28696204)
1. LTP and memory impairment caused by extracellular Aβ and Tau oligomers is APP-dependent.
Puzzo D; Piacentini R; Fá M; Gulisano W; Li Puma DD; Staniszewski A; Zhang H; Tropea MR; Cocco S; Palmeri A; Fraser P; D'Adamio L; Grassi C; Arancio O
Elife; 2017 Jul; 6():. PubMed ID: 28696204
[TBL] [Abstract][Full Text] [Related]
2. Extracellular Tau Oligomers Produce An Immediate Impairment of LTP and Memory.
Fá M; Puzzo D; Piacentini R; Staniszewski A; Zhang H; Baltrons MA; Li Puma DD; Chatterjee I; Li J; Saeed F; Berman HL; Ripoli C; Gulisano W; Gonzalez J; Tian H; Costa JA; Lopez P; Davidowitz E; Yu WH; Haroutunian V; Brown LM; Palmeri A; Sigurdsson EM; Duff KE; Teich AF; Honig LS; Sierks M; Moe JG; D'Adamio L; Grassi C; Kanaan NM; Fraser PE; Arancio O
Sci Rep; 2016 Jan; 6():19393. PubMed ID: 26786552
[TBL] [Abstract][Full Text] [Related]
3. Synaptic and memory dysfunction induced by tau oligomers is rescued by up-regulation of the nitric oxide cascade.
Acquarone E; Argyrousi EK; van den Berg M; Gulisano W; Fà M; Staniszewski A; Calcagno E; Zuccarello E; D'Adamio L; Deng SX; Puzzo D; Arancio O; Fiorito J
Mol Neurodegener; 2019 Jun; 14(1):26. PubMed ID: 31248451
[TBL] [Abstract][Full Text] [Related]
4. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W
Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830
[TBL] [Abstract][Full Text] [Related]
5. Lentivirus-mediated expression of human secreted amyloid precursor protein-alpha prevents development of memory and plasticity deficits in a mouse model of Alzheimer's disease.
Tan VTY; Mockett BG; Ohline SM; Parfitt KD; Wicky HE; Peppercorn K; Schoderboeck L; Yahaya MFB; Tate WP; Hughes SM; Abraham WC
Mol Brain; 2018 Feb; 11(1):7. PubMed ID: 29426354
[TBL] [Abstract][Full Text] [Related]
6. Human Brain-Derived Aβ Oligomers Bind to Synapses and Disrupt Synaptic Activity in a Manner That Requires APP.
Wang Z; Jackson RJ; Hong W; Taylor WM; Corbett GT; Moreno A; Liu W; Li S; Frosch MP; Slutsky I; Young-Pearse TL; Spires-Jones TL; Walsh DM
J Neurosci; 2017 Dec; 37(49):11947-11966. PubMed ID: 29101243
[TBL] [Abstract][Full Text] [Related]
7. Key Peptides and Proteins in Alzheimer's Disease.
Penke B; Bogár F; Paragi G; Gera J; Fülöp L
Curr Protein Pept Sci; 2019; 20(6):577-599. PubMed ID: 30605056
[TBL] [Abstract][Full Text] [Related]
8. Days to criterion as an indicator of toxicity associated with human Alzheimer amyloid-beta oligomers.
Gandy S; Simon AJ; Steele JW; Lublin AL; Lah JJ; Walker LC; Levey AI; Krafft GA; Levy E; Checler F; Glabe C; Bilker WB; Abel T; Schmeidler J; Ehrlich ME
Ann Neurol; 2010 Aug; 68(2):220-30. PubMed ID: 20641005
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices.
Rammes G; Hasenjäger A; Sroka-Saidi K; Deussing JM; Parsons CG
Neuropharmacology; 2011 May; 60(6):982-90. PubMed ID: 21310164
[TBL] [Abstract][Full Text] [Related]
10. Large Soluble Oligomers of Amyloid β-Protein from Alzheimer Brain Are Far Less Neuroactive Than the Smaller Oligomers to Which They Dissociate.
Yang T; Li S; Xu H; Walsh DM; Selkoe DJ
J Neurosci; 2017 Jan; 37(1):152-163. PubMed ID: 28053038
[TBL] [Abstract][Full Text] [Related]
11. Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer's Disease.
Kirouac L; Rajic AJ; Cribbs DH; Padmanabhan J
eNeuro; 2017; 4(2):. PubMed ID: 28374012
[TBL] [Abstract][Full Text] [Related]
12. Amyloid-β Peptide Is Needed for cGMP-Induced Long-Term Potentiation and Memory.
Palmeri A; Ricciarelli R; Gulisano W; Rivera D; Rebosio C; Calcagno E; Tropea MR; Conti S; Das U; Roy S; Pronzato MA; Arancio O; Fedele E; Puzzo D
J Neurosci; 2017 Jul; 37(29):6926-6937. PubMed ID: 28626017
[TBL] [Abstract][Full Text] [Related]
13. Soluble Aβ oligomers impair hippocampal LTP by disrupting glutamatergic/GABAergic balance.
Lei M; Xu H; Li Z; Wang Z; O'Malley TT; Zhang D; Walsh DM; Xu P; Selkoe DJ; Li S
Neurobiol Dis; 2016 Jan; 85():111-121. PubMed ID: 26525100
[TBL] [Abstract][Full Text] [Related]
14. MRZ-99030 - A novel modulator of Aβ aggregation: II - Reversal of Aβ oligomer-induced deficits in long-term potentiation (LTP) and cognitive performance in rats and mice.
Rammes G; Gravius A; Ruitenberg M; Wegener N; Chambon C; Sroka-Saidi K; Jeggo R; Staniaszek L; Spanswick D; O'Hare E; Palmer P; Kim EM; Bywalez W; Egger V; Parsons CG
Neuropharmacology; 2015 May; 92():170-82. PubMed ID: 25637092
[TBL] [Abstract][Full Text] [Related]
15. Hypercholesterolemia accelerates intraneuronal accumulation of Aβ oligomers resulting in memory impairment in Alzheimer's disease model mice.
Umeda T; Tomiyama T; Kitajima E; Idomoto T; Nomura S; Lambert MP; Klein WL; Mori H
Life Sci; 2012 Dec; 91(23-24):1169-76. PubMed ID: 22273754
[TBL] [Abstract][Full Text] [Related]
16. Intraneuronal beta-amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimer's disease transgenic mice.
España J; Giménez-Llort L; Valero J; Miñano A; Rábano A; Rodriguez-Alvarez J; LaFerla FM; Saura CA
Biol Psychiatry; 2010 Mar; 67(6):513-21. PubMed ID: 19664757
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's disease-like APP processing in wild-type mice identifies synaptic defects as initial steps of disease progression.
Audrain M; Fol R; Dutar P; Potier B; Billard JM; Flament J; Alves S; Burlot MA; Dufayet-Chaffaud G; Bemelmans AP; Valette J; Hantraye P; Déglon N; Cartier N; Braudeau J
Mol Neurodegener; 2016 Jan; 11():5. PubMed ID: 26759118
[TBL] [Abstract][Full Text] [Related]
18. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice.
Trinchese F; Liu S; Battaglia F; Walter S; Mathews PM; Arancio O
Ann Neurol; 2004 Jun; 55(6):801-14. PubMed ID: 15174014
[TBL] [Abstract][Full Text] [Related]
19. Mutation-induced loss of APP function causes GABAergic depletion in recessive familial Alzheimer's disease: analysis of Osaka mutation-knockin mice.
Umeda T; Kimura T; Yoshida K; Takao K; Fujita Y; Matsuyama S; Sakai A; Yamashita M; Yamashita Y; Ohnishi K; Suzuki M; Takuma H; Miyakawa T; Takashima A; Morita T; Mori H; Tomiyama T
Acta Neuropathol Commun; 2017 Jul; 5(1):59. PubMed ID: 28760161
[TBL] [Abstract][Full Text] [Related]
20. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
